Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Halozyme Therapeutics

Halozyme Therapeutics reported $162.14M in Sales Revenues for its fiscal quarter ending in March of 2023.

Sales Change
Acadia Pharmaceuticals ACAD:US USD 118.46M 18.03M
Agios Pharmaceuticals AGIO:US USD 5.61M 1.3M
Alnylam Pharmaceuticals ALNY:US USD 319.29M 15.74M
Amarin AMRN:US USD 85.98M 4.27M
Amgen AMGN:US USD 6.1B 734M
Baxter International BAX:US USD 3.65B 238M
Cara Therapeutics CARA:US USD 6.16M 2.9M
Cytokinetics CYTK:US USD 4.61M 2.66M
Eli Lilly LLY:US USD 6.96B 341.8M
Esperion Therapeutics ESPR:US USD 24.33M 5.51M
Halozyme Therapeutics HALO:US USD 162.14M 19.35M
Immunogen IMGN:US USD 49.87M 8.7M
Intercept Pharmaceuticals ICPT:US USD 67.96M 9.26M
Intra Cellular Therapies ITCI:US USD 95.31M 7.44M
Intrexon XON:US USD 1.85M 88K
Ionis Pharmaceuticals IONS:US USD 130.52M 21.36M
MannKind MNKD:US USD 40.63M 4.57M
Nektar Therapeutics NKTR:US USD 21.59M 429K
Peregrine Pharmaceuticals PPHM:US USD 38.02M 3.26M
Pfizer PFE:US USD 18.28B 6.01B
Rigel Pharmaceuticals RIGL:US USD 26.07M 25.21M
United Therapeutics UTHR:US USD 506.9M 15.4M
Vanda Pharmaceuticals VNDA:US USD 125M 60.51M